A translational research study testing the biology of monocyte-derived dendritic cells and immune effector cells from subjects with advanced renal cell cancer currently treated with Sutent (Sunitinib) or Nexavar (Sorafenib)

Trial Profile

A translational research study testing the biology of monocyte-derived dendritic cells and immune effector cells from subjects with advanced renal cell cancer currently treated with Sutent (Sunitinib) or Nexavar (Sorafenib)

Not stated
Phase of Trial: Phase II

Latest Information Update: 12 Apr 2007

At a glance

  • Drugs Sorafenib (Primary) ; Sunitinib (Primary)
  • Indications Renal cancer
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top